MX350719B - Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria. - Google Patents

Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria.

Info

Publication number: MX350719B
Authority: MX; Mexico
Prior art keywords: treatment; inflammatory hyperpigmentation; bakuchiol; post inflammatory; bakuchiol compositions
Prior art date: 2011-02-02

Application number

MX2013008890A

Other languages

English (en)

Spanish (es)

Other versions

MX2013008890A (es

Inventor

Jia Qi

Feng Hong Mei

Alfaro Brownell Lidia

Original Assignee

Unigen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-02

Filing date

2012-02-02

Publication date

2017-09-14

2012-02-02 Application filed by Unigen Inc filed Critical Unigen Inc

2012-02-02 Priority claimed from PCT/US2012/023686 external-priority patent/WO2012106551A1/fr

2013-10-17 Publication of MX2013008890A publication Critical patent/MX2013008890A/es

2017-09-14 Publication of MX350719B publication Critical patent/MX350719B/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Birds (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MX2013008890A 2011-02-02 2012-02-02 Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria. MX350719B (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161438890P	2011-02-02	2011-02-02
PCT/US2011/026594 WO2012105990A1 (fr)	2011-02-02	2011-03-01	Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire
PCT/US2012/023686 WO2012106551A1 (fr)	2011-02-02	2012-02-02	Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire

Publications (2)

Publication Number	Publication Date
MX2013008890A MX2013008890A (es)	2013-10-17
MX350719B true MX350719B (es)	2017-09-14

Family

ID=46603028

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX2013008890A MX350719B (es)	2011-02-02	2012-02-02	Composiciones de bakuchiol para el tratamiento de hiperpigmentacion post-inflamatoria.

Country Status (8)

Country	Link
KR (5)	KR101954118B1 (fr)
CN (2)	CN103458882B (fr)
AU (1)	AU2012212153B9 (fr)
BR (1)	BR112013019798A2 (fr)
CA (4)	CA3128715A1 (fr)
MX (1)	MX350719B (fr)
PH (1)	PH12013501632A1 (fr)
WO (1)	WO2012105990A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10471035B2 (en)	2014-10-20	2019-11-12	Sunny BioDiscovery	Compositions and methods for using esters of meroterpenes and of other resveratrol analogues
CN105675741A (zh) *	2015-12-30	2016-06-15	成都九芝堂金鼎药业有限公司	一种测定生发丸中有效成分含量的方法
KR20190116858A (ko)	2018-04-05	2019-10-15	주식회사 엑소코바이오	줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 염증후 과색소침착의 예방, 완화, 감소 내지는 제거 용도
KR102610938B1 (ko)	2018-08-31	2023-12-08	(주)아모레퍼시픽	유화입자를 형성하는 나노캡슐 및 이를 포함하는 유화 조성물
KR102887367B1 (ko) *	2020-02-27	2025-11-14	(주)아모레퍼시픽	보습 효과를 갖는 조성물
CN111544317B (zh) *	2020-04-29	2022-01-14	珀莱雅化妆品股份有限公司	一种抗衰老组合物阳离子纳米脂质体及其制备方法与应用
CN114478196B (zh) *	2021-01-27	2023-11-10	江苏巴帝恩生物科技有限公司	一种从春榆根里提取补骨脂酚并纯化的方法及在化妆品中的应用
US20250018312A1 (en) *	2023-07-03	2025-01-16	Anju Majeed	Furanocoumarins free bakuchiol compositions and their method of preparation thereof
KR102899265B1 (ko) *	2024-03-29	2025-12-10	한국세라믹기술원	항산화 및 항염 활성이 개선된 바쿠치올 나노입자의 제조 방법 및 상기 방법에 의해 제조된 바쿠치올 나노입자의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2617473B2 (ja)	1987-06-30	1997-06-04	キヤノン株式会社	情報入力装置
BRPI0608796B8 (pt) *	2005-05-09	2021-05-25	Unigen Pharmaceuticals Inc	método para a preparação de um extrato de planta compreendendo bacuquiol
EP2144590B1 (fr) *	2007-05-14	2018-08-01	Sytheon Ltd.	Compositions de traitement pour la peau et procédés

2011
- 2011-03-01 WO PCT/US2011/026594 patent/WO2012105990A1/fr not_active Ceased
2012
- 2012-02-02 KR KR1020137022953A patent/KR101954118B1/ko active Active
- 2012-02-02 PH PH1/2013/501632A patent/PH12013501632A1/en unknown
- 2012-02-02 BR BR112013019798A patent/BR112013019798A2/pt not_active Application Discontinuation
- 2012-02-02 AU AU2012212153A patent/AU2012212153B9/en active Active
- 2012-02-02 MX MX2013008890A patent/MX350719B/es active IP Right Grant
- 2012-02-02 CN CN201280015007.XA patent/CN103458882B/zh active Active
- 2012-02-02 KR KR1020217038833A patent/KR102525516B1/ko active Active
- 2012-02-02 CA CA3128715A patent/CA3128715A1/fr active Pending
- 2012-02-02 KR KR1020207026173A patent/KR102333655B1/ko active Active
- 2012-02-02 KR KR1020237013482A patent/KR102642352B1/ko active Active
- 2012-02-02 KR KR1020197005663A patent/KR102156731B1/ko active Active
- 2012-02-02 CN CN201510390680.7A patent/CN105147533B/zh active Active
- 2012-02-02 CA CA3128718A patent/CA3128718A1/fr active Pending
- 2012-02-02 CA CA3128711A patent/CA3128711C/fr active Active
- 2012-02-02 CA CA2826262A patent/CA2826262C/fr active Active

Also Published As

Publication number	Publication date
HK1215792A1 (zh)	2016-09-15
KR20140008364A (ko)	2014-01-21
CN103458882B (zh)	2015-08-05
KR102333655B1 (ko)	2021-12-01
KR102642352B1 (ko)	2024-02-28
CN103458882A (zh)	2013-12-18
AU2012212153B2 (en)	2017-04-06
CN105147533B (zh)	2018-07-31
CA3128711C (fr)	2026-03-10
CA3128715A1 (fr)	2012-08-09
KR20190025740A (ko)	2019-03-11
CA3128711A1 (fr)	2012-08-09
KR101954118B1 (ko)	2019-03-05
KR20200108120A (ko)	2020-09-16
CA2826262A1 (fr)	2012-08-09
CA3128718A1 (fr)	2012-08-09
BR112013019798A2 (pt)	2017-07-04
AU2012212153B9 (en)	2017-05-11
KR102525516B1 (ko)	2023-04-24
WO2012105990A1 (fr)	2012-08-09
KR20230058727A (ko)	2023-05-03
CN105147533A (zh)	2015-12-16
AU2012212153A1 (en)	2013-08-29
PH12013501632A1 (en)	2019-03-22
KR20210145864A (ko)	2021-12-02
KR102156731B1 (ko)	2020-09-16
CA2826262C (fr)	2021-10-26
MX2013008890A (es)	2013-10-17

Legal Events

Date	Code	Title	Description
2017-09-14	FG	Grant or registration

Publication	Publication Date	Title
WO2012106551A1 (fr)	2012-08-09	Compositions de bakuchiol pour le traitement d'une hyperpigmentation post-inflammatoire
PH12013501632A1 (en)	2019-03-22	Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
ECSP13013074A (es)	2014-01-31	Nuevos derivados de piridina
MX2019001253A (es)	2019-07-04	Conjugados de proteina-agente activo y metodo para su preparacion.
ECSP13013021A (es)	2014-01-31	Compuestos de benzotiazol y su uso farmacéutico
CO6541606A2 (es)	2012-10-16	Espiroindolinona- pirrolidinas
CU20140068A7 (es)	2014-12-26	Triazolopiridinas sustituidas
CL2014002742A1 (es)	2015-02-13	Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr) (divisional de solicitud 1291-2014)
CL2013000063A1 (es)	2013-05-03	Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
PE20200844A1 (es)	2020-08-18	Derivados 11-hidroxil-6-sustituidos de acidos biliares y conjugados de aminoacidos de los mismos como moduladores de receptores farnesoides x
GT201300001A (es)	2014-04-29	Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
EA201390804A1 (ru)	2013-10-30	Лекарственная форма лакозамида для приема один раз в сутки
ECSP12012104A (es)	2012-09-28	Inhibidores de virus flaviviridae
CU20120171A7 (es)	2013-05-31	Triazolopiridinas sustituidas
CR20150204A (es)	2015-05-18	Nuevos derivados de piridina
ECSP12012217A (es)	2012-11-30	Combinación Farmaceutica para el tratamiento del dolor
MX2015003701A (es)	2015-10-29	Composiciones para tratamiento.
MX2014012742A (es)	2015-04-08	Composicion para el tratamiento de transtornos metabólicos.
DOP2013000304A (es)	2014-04-15	Moduladores alostéricos positivos del receptor de acetilcolina nicotínico
PH12014500990A1 (en)	2014-08-04	Methods for treating gout flares
CO7141430A2 (es)	2014-12-12	Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
CR20150282A (es)	2015-09-01	Método para sincronización del tiempo de inseminación en cerdas jóvenes
DOP2013000131A (es)	2013-11-15	Composiciones y métodos para tratar el cáncer usando un inhibidor de pi3k y un inhibidor de mek
UY31775A (es)	2010-11-30	Compuestos heterocíclicos como inhibidores de mek
CR20130583A (es)	2014-03-03	Moduladores alostéricos positivos del receptor de acetilcolina nicotínico